B7-H3-targeted CAR-T cell therapy for solid tumors. PMID: 35855615
B7-H3 Immune Checkpoint Protein in Human Cancer. PMID: 31099317
The role of B7-H3 in tumors and its potential in clinical application. PMID: 34678689
Histamine H3 receptor antagonists - Roles in neurological and endocrine diseases and diabetes mellitus. PMID: 35447544
B7-H3 and its role in bone cancers. PMID: 31060912
Dynamic Activity of Histone H3-Specific Chaperone Complexes in Oncogenesis. PMID: 35087762
B7-H3 in tumors: friend or foe for tumor immunity? PMID: 29299639
The micronuclear histone H3 clipping in the unicellular eukaryote Tetrahymena thermophila. PMID: 37078088
Histamine H3-receptor isoforms. PMID: 15597144
The Role of the TSK/TONSL-H3.1 Pathway in Maintaining Genome Stability in Multicellular Eukaryotes. PMID: 36012288
Transcription-coupled H3.3 recycling: A link with chromatin states. PMID: 35595602
Histone Variant H3.3 Mutations in Defining the Chromatin Function in Mammals. PMID: 33353064
Histone H3 dynamics in plant cell cycle and development. PMID: 25060842
H3.3 turnover: a mechanism to poise chromatin for transcription, or a response to open chromatin? PMID: 24700556
Histamine H₃ receptors, the complex interaction with dopamine and its implications for addiction. PMID: 23647606
Histamine H3 receptor agonists. PMID: 15544556
Imaging features associated with H3 K27-altered and H3 G34-mutant gliomas: a narrative systematic review. PMID: 36397143
Histone H3.3 phosphorylation promotes heterochromatin formation by inhibiting H3K9/K36 histone demethylase. PMID: 35451487
Histamine H3 receptor function and ligands: recent developments. PMID: 22931528
Stable inheritance of H3.3-containing nucleosomes during mitotic cell divisions. PMID: 35523900
Histone H3 variants specify modes of chromatin assembly. PMID: 12177448
The histone variant H3.3 claims its place in the crowded scene of epigenetics. PMID: 28284043
Histamine H3 receptors--general characterization and their function in the cardiovascular system. PMID: 9670104
B7-H3 blockade decreases macrophage inflammatory response and alleviates clinical symptoms of arthritis. PMID: 34979195
Histamine H3 antagonists as wake-promoting and pro-cognitive agents. PMID: 18673168
HIRA-dependent boundaries between H3 variants shape early replication in mammals. PMID: 35381196
Potential functions of histone H3.3 lysine 56 acetylation in mammals. PMID: 33902396
The human histone H3 complement anno 2011. PMID: 21782046
Histamine H3 receptor antagonists go to clinics. PMID: 19043195
B7-H3 inhibits apoptosis of gastric cancer cell by interacting with Fibronectin. PMID: 35003371
Histamine H3 antagonists for treatment of cognitive deficits in CNS diseases. PMID: 20166960
Histone H3 methylation orchestrates transcriptional program in mouse spermatogenic cell line. PMID: 32051348
An update on histamine H3 receptors and gastrointestinal functions. PMID: 7555464
Histamine H3 receptor antagonists in relation to epilepsy and neurodegeneration: a systemic consideration of recent progress and perspectives. PMID: 22758607
Procognitive properties of drugs with single and multitargeting H3 receptor antagonist activities. PMID: 24836924
The histamine H3 receptor: an attractive target for the treatment of cognitive disorders. PMID: 18469850
[Research Progress on Co-stimulating Molecule B7-H3 in Hematological Malignancies]. PMID: 26708906
H3 receptor gene is cloned at last. PMID: 10637648
PRC2-independent actions of H3.3K27M in embryonic stem cell differentiation. PMID: 36156096
NASP maintains histone H3-H4 homeostasis through two distinct H3 binding modes. PMID: 35489058
The evolution of histamine H₃ antagonists/inverse agonists. PMID: 21261594
Modulation of neurotransmitter release via histamine H3 heteroreceptors. PMID: 8020871
The incorporation loci of H3.3K36M determine its preferential prevalence in chondroblastomas. PMID: 33762579
B7-H3-Targeted CAR-T Cells Exhibit Potent Antitumor Effects on Hematologic and Solid Tumors. PMID: 32346608
Differential antibody response to EBV proteome following EBVST immunotherapy in EBV-associated lymphomas., PMID:39908567
EBV-induced upregulation of CD55 reduces the efficacy of cetuximab treatment in nasopharyngeal carcinoma., PMID:39695702
Differential EBV protein-specific antibody response between responders and non-responders to EBVSTs immunotherapy., PMID:39211169
A proteome-wide analysis unveils a core Epstein-Barr virus antibody signature of classic Hodgkin lymphoma across ethnically diverse populations., PMID:38995124
Recent Advances in Assessing the Clinical Implications of Epstein-Barr Virus Infection and Their Application to the Diagnosis and Treatment of Nasopharyngeal Carcinoma., PMID:38276183
Serum Anti-Zta and Anti-LMP1 Antibodies in Oropharyngeal Cancer Related to Epstein-Barr Virus-Diagnostic Usefulness., PMID:38254830
CD30 protects EBV-positive diffuse large B-cell lymphoma cells against mitochondrial dysfunction through BNIP3-mediated mitophagy., PMID:38211650
LMP1 and EBNA2 constitute a minimal set of EBV genes for transformation of human B cells., PMID:38169736
Epstein-Barr virus infection as potential indicator of the occurrence and clinical presentation of systemic lupus erythematosus., PMID:38146370
Understanding the role of membrane cholesterol upon Epstein Barr virus infection in astroglial cells., PMID:37876925
Molecular detection of Epstein-Barr virus among Sudanese patients diagnosed with Hashimoto's thyroiditis., PMID:37858193
Suppression of Nasopharyngeal and Gastric Tumor Growth in a Mouse Model by Antibodies to Epstein-Barr Virus LMP1 Protein., PMID:37512884
Vaccination against Epstein-Barr Latent Membrane Protein 1 Protects against an Epstein-Barr Virus-Associated B Cell Model of Lymphoma., PMID:37508413
Inhibitory NKG2A+ and absent activating NKG2C+ NK cell responses are associated with the development of EBV+ lymphomas., PMID:37426645
Novel Bifunctional Affibody Molecules with Specific Binding to Both EBV LMP1 and LMP2 for Targeted Therapy of Nasopharyngeal Carcinoma., PMID:37373272
Epstein-Barr virus in breast carcinoma and in triple negative cases impact on clinical outcomes., PMID:37116366
Epstein-Barr Virus-Positive Leiomyosarcoma in Immunocompetent Patients., PMID:36951222
Epstein‒Barr virus and human herpesvirus 6 infection in patients with systemic lupus erythematosus., PMID:36782252
Association of human papillomavirus and Epstein-Barr virus with squamous cell carcinoma of upper aerodigestive tract., PMID:36683943
PD-L1 and EBV LMP1 expressions in classic Hodgkin lymphomas and its correlation with clinicopathological parameters and prognosis., PMID:36326378
Incidence of Epstein-Barr Virus Among Women With Breast Cancer Using Monoclonal Antibodies for Latent Membrane Protein 1 (LMP1)., PMID:35478129
Cumulative Roles for Epstein-Barr Virus, Human Endogenous Retroviruses, and Human Herpes Virus-6 in Driving an Inflammatory Cascade Underlying MS Pathogenesis., PMID:34790199
Identifying Epstein-Barr virus peptide sequences associated with differential IgG antibody response., PMID:34728343
Uncovering early events in primary Epstein-Barr virus infection using a rabbit model., PMID:34707156
Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for EBV-Associated Diseases., PMID:34691042
Plasmablastic lymphomas show restricted EBV latency profile and MYC gene aberrations., PMID:34612761
Epstein-Barr Virus Latent Membrane Protein-1 Expression in Nasopharyngeal Carcinoma., PMID:34546798
Updating targets for natural killer/T-cell lymphoma immunotherapy., PMID:33628584
Epstein-Barr Functional Mimicry: Pathogenicity of Oncogenic Latent Membrane Protein-1 in Systemic Lupus Erythematosus and Autoimmunity., PMID:33613527
Selection of new immunotherapy targets for NK/T cell lymphoma., PMID:33312349
A Hyperactive RelA/p65-Hexokinase 2 Signaling Axis Drives Primary Central Nervous System Lymphoma., PMID:33067267
Epstein-Barr virus infection in patients with chronic gastritis without Helicobacter pylori infection., PMID:32343232
A phase II study of ibrutinib in combination with rituximab-cyclophosphamide-doxorubicin hydrochloride-vincristine sulfate-prednisone therapy in Epstein-Barr virus-positive, diffuse large B cell lymphoma (54179060LYM2003: IVORY study): results of the final analysis., PMID:32333154
[Expression of LMP-1 protein in tumor cells and glandular epithelium of the peritumoral tissue in gastric cancer]., PMID:31851189
CD137 Co-Stimulation Improves The Antitumor Effect Of LMP1-Specific Chimeric Antigen Receptor T Cells In Vitro And In Vivo., PMID:31807014
Construction of Epstein-Bar virus cocktail peptide fused with Fcγ of IgG: as a potential delivery system for vaccine development., PMID:31739735
Evaluation of the antibody response to the EBV proteome in EBV-associated classical Hodgkin lymphoma., PMID:31618442
Total Antioxidant Status (TAS), Superoxide Dismutase (SOD), and Glutathione Peroxidase (GPx) in Oropharyngeal Cancer Associated with EBV Infection., PMID:31360295
Exosomal cyclophilin A as a novel noninvasive biomarker for Epstein-Barr virus associated nasopharyngeal carcinoma., PMID:31063269
Fibronectin promotes nasopharyngeal cancer cell motility and proliferation., PMID:30551431
Epstein Barr Virus in Patients with Nephropathy Associated with Systemic Lupus Erythematous, Pilot Study in Egyptian Patients., PMID:30242993
Bystander inhibition of humoral immune responses by Epstein-Barr virus LMP1., PMID:30137504
Epstein-Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas., PMID:29946193
Novel Immunotherapy Options for Extranodal NK/T-Cell Lymphoma., PMID:29761078
The Relationship Between Environmental Factors and the Profile of Epstein-Barr Virus Antibodies in the Lytic and Latent Infection Periods in Healthy Populations from Endemic and Non-Endemic Nasopharyngeal Carcinoma Areas in China., PMID:29606628
The Possible Effect of B-Cell Epitopes of Epstein-Barr Virus Early Antigen, Membrane Antigen, Latent Membrane Protein-1, and -2A on Systemic Lupus Erythematosus., PMID:29497417
Epstein-Barr virus infection and type I interferon signature in patients with systemic lupus erythematosus., PMID:29338588
The potential of currently unavailable herpes virus vaccines., PMID:29313728
Prevalence and molecular profiling of Epstein Barr virus (EBV) among healthy blood donors from different nationalities in Qatar., PMID:29228016
Analysis of Immunogenicity of Intracellular CTAR Fragments of Epstein-Barr Virus Latent Phase Protein LMP1., PMID:29063322
For research use only. Not for human or drug use.
